S100B and neoplasm: In the balanced validation cohort-B (increased to n = 86 per the discovery cohort size), there was a significant association between S100B levels and tumor volume in male VS patients (Padj = 0.051 was considered significant for FDR of 0.10) (Fig. 4O).